iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Update

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totaling 7,345 shares, a growth of 570.8% from the April 15th total of 1,095 shares. Currently, 2.0% of the company’s stock are short sold. Based on an average daily volume of 3,855 shares, the days-to-cover ratio is currently 1.9 days.

iShares Health Innovation Active ETF Trading Up 1.5%

NYSEARCA:BMED traded up $0.41 during mid-day trading on Tuesday, hitting $27.97. The stock had a trading volume of 2,352 shares, compared to its average volume of 4,395. The stock has a 50-day simple moving average of $28.87 and a two-hundred day simple moving average of $29.78. The company has a market capitalization of $10.07 million, a PE ratio of 24.91 and a beta of 0.75. iShares Health Innovation Active ETF has a twelve month low of $23.23 and a twelve month high of $32.19.

Institutional Trading of iShares Health Innovation Active ETF

An institutional investor recently bought a new position in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. acquired a new position in shares of iShares Health Innovation Active ETF (NYSEARCA:BMED) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned approximately 3.63% of iShares Health Innovation Active ETF at the end of the most recent quarter.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.